Table 3.
Study | Species | Exp. | Region | Genes | Mark(s) | Findings |
---|---|---|---|---|---|---|
(Pandey et al., 2015) | Sprague Dawley rats | Intermittent, 2g/kg i.p. | CeA, MeA | Hdac2, Hdac4, Bdnf-I, Bdnf-IV, Arc | H3K9ac, H3K9/14ac | - Decreased H3K9ac and increased HDAC2 and HDAC4. - Increased HDAC activity |
- TSA prevents molecular effects, anxiety and alcohol consumption | ||||||
(Sakharkar et al., 2016) | Sprague Dawley rats | Intermittent, 2g/kg i.p. | Hipp. | Ki-67, DCX, Bdnf-I, Bdnf-IV, CBP | H3K9ac, H3K9/14ac | - Decreased H3K9ac and CBP in CA1–3 regions, -Increased HDAC activity |
- TSA prevents anxiety, restores markers of neurogenesis and decreases of H3K9/14ac at BDNF-I and BDNF-IV promoters | ||||||
(Mulholland et al., 2018) | Sprague Dawley rats | 5g/kg i.g. | Hipp. | Fmr1 | H3K9/14ac,H3K27ac | - Donepezil prevents increases of Fmr1 mRNA and increased H3K27ac at Fmr1 gene |
(Bohnsack et al., 2019) | Humans | Earlyage of onset | Amgydala | BDNF, Arc | H3K27ac | - Decreased Arc and BDNF expression and decrease in H3K27ac at regulatory elements |
(Zhang et al., 2018) | Sprague Dawley rats | Intermittent 2g/kg i.p. | CeA, MeA | CBP, P300, CREB | H3K9/14Ac | - Decreased CBP, P300, and CREB expression |
- Decreased H3K9/14ac at promoters of CBP, P300, and CREB. |
Abbreviations: Exp. = exposure, i.p. = intraperitoneal, i.g. = intragastric, CeA = central nucleus of the amygdala, MeA = medial nucleus of the amygdala, Hipp = hippocampus.